These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 14317099)

  • 1. [NEW PHARMACOLOGIC PRODUCTS. 3. THE ANTIFIBRINOLYTIC AGENT EPSILON-AMINOCAPROIC ACID].
    STRIEGLER G
    Pharm Prax; 1964; 11():256-8. PubMed ID: 14317099
    [No Abstract]   [Full Text] [Related]  

  • 2. [ANTIPLASMIN ACTIVITY OF THE PANCREATIC TRYPSIN INHIBITOR AND OF EPSILON-AMINOCAPROIC ACID].
    DEBARBIERI A; SCEVOLA ME; FRANCHINI M
    Boll Chim Farm; 1964 Jan; 103():37-40. PubMed ID: 14131376
    [No Abstract]   [Full Text] [Related]  

  • 3. [AN EFFECTIVE ANTIFIBRINOLYTIC AGENT: EPSILON-AMINOCAPROIC ACID].
    GROSSI F
    Clin Ter; 1963 Jul; 26():73-8. PubMed ID: 14050038
    [No Abstract]   [Full Text] [Related]  

  • 4. EFFECT OF ANTICOAGULANT, FIBRINOLYTIC, AND ANTIFIBRINOLYTIC AGENTS ON EXPERIMENTAL HYALINE MEMBRANES.
    FUJIKURA T
    Am J Obstet Gynecol; 1964 Dec; 90():850-3. PubMed ID: 14241506
    [No Abstract]   [Full Text] [Related]  

  • 5. [DISSOCIATED EFFECTS OF A NEW ANTIFIBRINOLYTIC AGENT (EPSILON-AMINOCAPROIC ACID) INJECTED "IN VIVO", ON "IN VITRO" FIBRINOLYSIS TESTS].
    WEISS M; YVER J; SAMAMA M; DUBOST C
    Presse Med (1893); 1963 Sep; 71():1879-80. PubMed ID: 14091607
    [No Abstract]   [Full Text] [Related]  

  • 6. [CLINICAL EXPERIENCES WITH EPSILON-AMINOCAPROIC ACID AS AN ANTIFIBRINOLYTIC AGENT IN VARIOUS OBSTETRICAL DISORDERS].
    PALACIO S; CANO A; YEPES E
    Rev Colomb Obstet Ginecol; 1964; 15():413-9. PubMed ID: 14258173
    [No Abstract]   [Full Text] [Related]  

  • 7. [THE PHARMACOLOGIC PROPERTIES OF A NEW ANTIFIBRINOLYTIC, PARA-AMINOMETHYLBENZOIC ACID].
    MARKWARDT F; HAUSTEIN KO; KLOECKING HP
    Arch Int Pharmacodyn Ther; 1964 Nov; 152():223-33. PubMed ID: 14248348
    [No Abstract]   [Full Text] [Related]  

  • 8. AN ANTIFIBRINOLYTIC AGENT: AMINOCAPROIC ACID.
    COVENTRY MB
    JAMA; 1965 Feb; 191():489-90. PubMed ID: 14238032
    [No Abstract]   [Full Text] [Related]  

  • 9. METHOD FOR DETERMINING EPSILON-AMINOCAPROIC ACID (EACA) IN BLOOD PLASMA, BASED ON THE ANTIFIBRINOLYTIC PROPERTIES OF THIS COMPOUND.
    WOLOSOWICZ N; NIEWIAROWSKI S; CZEREPKO K
    Thromb Diath Haemorrh; 1964 Jan; 10():309-16. PubMed ID: 14113373
    [No Abstract]   [Full Text] [Related]  

  • 10. [A NEW METHOD OF THE ANALYSIS OF EPSILON-AMINOCAPROIC ACID (EACA) AND AMINOMETHYLCYCLOHEXANE CARBOXYLIC ACID (AMCHA), THE POTENT ANTIFIBRINOLYTIC AGENTS].
    TAKATA Y; TAKATA A; OKAMOTO U
    Nihon Seirigaku Zasshi; 1964 May; 26():281-5. PubMed ID: 14172890
    [No Abstract]   [Full Text] [Related]  

  • 11. [ON THE THERAPEUTIC USE OF EPSILON-AMINOCAPROIC ACID AND OTHER ANTIFIBRINOLYTICS].
    PERLICK E
    Dtsch Gesundheitsw; 1964 May; 19():900-3. PubMed ID: 14220146
    [No Abstract]   [Full Text] [Related]  

  • 12. [CLINICAL RESULTS OBTAINED BY THE USE OF ANTIFIBRINOLYTIC AGENT].
    LENOIR P; TURPIN J; PAWLOTSKY Y; NOURY S; GOUFFAULT J; BOUREL M
    Therapie; 1964; 19():1651-6. PubMed ID: 14242733
    [No Abstract]   [Full Text] [Related]  

  • 13. Reduction of postprostatectomy bleeding by epsilon-aminocaproic acid.
    Sack E; Spaet TH; Gentile RL; Hudson PB
    N Engl J Med; 1962 Mar; 266():541-3. PubMed ID: 14495863
    [No Abstract]   [Full Text] [Related]  

  • 14. [ANTIPLASMIN DRUGS].
    MATSUOKA S; OGUCHI G
    Sogo Rinsho; 1963 Oct; 12():1986-91. PubMed ID: 14092546
    [No Abstract]   [Full Text] [Related]  

  • 15. ON THE INTERACTION OF FIBRINOLYSIN (PLASMIN) WITH THE INHIBITORS ANTIFIBRINOLYSIN AND SOYBEAN TRYPSIN INHIBITOR.
    NANNINGA LB; GUEST MM
    Arch Biochem Biophys; 1964 Dec; 108():542-51. PubMed ID: 14244698
    [No Abstract]   [Full Text] [Related]  

  • 16. [THE ACETYL DERIVATIVE EPSILON-AMINOCAPROIC ACID AS AN AGENT FAVORING THE INDUCTION AND DEVELOPMENT OF EHRLICH'S CARCINOMA IN THE RAT].
    BONMASSAR E; PRADA A; ROBOTTI CA
    Boll Soc Ital Biol Sper; 1963 Oct; 39():1230-2. PubMed ID: 14119248
    [No Abstract]   [Full Text] [Related]  

  • 17. [ANTIFIBRINOLYTIC AGENTS].
    ZWEIBAUM A; JOSSO F
    Rev Prat; 1963 Dec; 13():SUPPL 135-8. PubMed ID: 14099272
    [No Abstract]   [Full Text] [Related]  

  • 18. THE PREVENTION OF HEMORRHAGE WITH ANTICOAGULANTS--AN EXPLORATORY STUDY OF A PARADOX.
    ROBERTS HR; PENICK GD; WEBSTER WP; BRINKHOUS KM
    Ann N Y Acad Sci; 1964 Jul; 115():67-77. PubMed ID: 14192862
    [No Abstract]   [Full Text] [Related]  

  • 19. [THE EFFECT OF EPSILON-AMINOCAPROIC ACID (EACA) ON BLOOD COAGULATION TIME].
    GAERTNER H; LISIEWICZ J; SIEROSLAWSKI H; SZIRMAI E
    Acta Med Okayama (1952); 1963 Jun; 17():123-6. PubMed ID: 14121937
    [No Abstract]   [Full Text] [Related]  

  • 20. MECHANISM OF ACTION OF EPSILON AMINOCAPROIC ACID IN THE CONTROL OF HEMORRHAGE.
    DEYSINE M; CLIFFTON EE
    Ann N Y Acad Sci; 1964 Jul; 115():291-7. PubMed ID: 14192834
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.